Detalhe da pesquisa
1.
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity.
Cell
; 177(7): 1701-1713.e16, 2019 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31155232
2.
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant.
Cell Rep Med
; 3(10): 100783, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36260981
3.
Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control.
Open Res Eur
; 1: 107, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35967081